Targeting Pim1 kinase in the treatment of peanut allergy

Bibliography

• Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2010;125:S116-25
   Web of Science ®Google Scholar
• Grundy J, Matthews S, Bateman B, et al. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J Allergy Clin Immunol 2002;110:784-9
   PubMed Web of Science ®Google Scholar
• Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191-3
   PubMed Web of Science ®Google Scholar
• Mullins RJ, Dear KB, Tang ML. Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. J Allergy Clin Immunol 2009;123:689-93
   PubMed Web of Science ®Google Scholar
• Arias K, Chu DK, Flader K, et al. Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice. J Allergy Clin Immunol 2011;127:1552-61
   PubMedGoogle Scholar
• Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol 2008;8:205-17
   PubMed Web of Science ®Google Scholar
• Wang M, Takeda K, Shiraishi Y, et al. Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway. J Allergy Clin Immunol 2010;126:306-16
   PubMed Web of Science ®Google Scholar
• Wang M, Okamoto M, Domenico J, et al. Inhibition of Pim1 kinase prevents peanut allergy by enhancing Runx3 expression and suppressing T(H)2 and T(H)17 T-cell differentiation. J Allergy Clin Immunol 2012;130:932-44
   Google Scholar
• Knight AK, Blázquez AB, Zhang S, et al. CD4 T cells activated in the mesenteric lymph node mediate gastrointestinal food allergy in mice. Am J Physiol Gastrointest Liver Physiol 2007;293:G1234-43
   PubMed Web of Science ®Google Scholar
• Brandt EB, Strait RT, Hershko D, et al. Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 2003;112:1666-77
   PubMed Web of Science ®Google Scholar
• Forbes EE, Groschwitz K, Abonia JP, et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008;205:897-913
   PubMed Web of Science ®Google Scholar
• Eigenmann PA. T lymphocytes in food allergy: overview of an intricate network of circulating and organ-resident cells. Pediatr Allergy Immunol 2002;13:162-71
   PubMed Web of Science ®Google Scholar
• Eigenmann PA, Huang SK, Ho DG, et al. Human T cell clones and cell lines specific to ovomucoid recognize different domains and consistently express IL-5. Adv Exp Med Biol 1996;409:217
   Google Scholar
• Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest 2003;111:1065-72
   PubMed Web of Science ®Google Scholar
• Fox CJ, Hammerman PS, Thompson CB. The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 2005;201:259-66
   PubMed Web of Science ®Google Scholar
• Mikkers H, Nawijn M, Allen J, et al. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 2004;24:6104-15
   PubMed Web of Science ®Google Scholar
• Wang Z, Bhattacharya N, Weaver M, et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci 2001;2:167-79
   PubMedGoogle Scholar
• Saris CJ, Domen J, Berns A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J 1991;10:655-64
   PubMed Web of Science ®Google Scholar
• Bachmann M, Moroy T. The serine/threonine kinase Pim-1. Intl J Biochem Cell Biol 2005;37:726-30
   PubMed Web of Science ®Google Scholar
• Xie Y, Xu K, Dai B, et al. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs. Oncogene 2006;25:70-8
   PubMed Web of Science ®Google Scholar
• Chen WW, Chan DC, Donald C, et al. Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res 2005;3:443-51
   PubMed Web of Science ®Google Scholar
• Brault L, Gasser C, Bracher F, et al. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica 2010;95:1004-15
   PubMed Web of Science ®Google Scholar
• Temple R, Allen E, Fordham J, et al. Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes. Am J Respir Cell Mol Biol 2001;25:425-33
   PubMed Web of Science ®Google Scholar
• Aho TL, Lund RJ, Ylikoski EK, et al. Expression of human pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation. Immunology 2005;116:82-8
   Google Scholar
• Jackson LJ, Pheneger JA, Pheneger TJ, et al. The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease. Cell Immunol 2012;272:200-13
   Google Scholar
• Stout BA, Bates ME, Liu LY, et al. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 2004;173:6409-17
   PubMed Web of Science ®Google Scholar
• Shin YS, Takeda K, Shiraishi Y, et al. Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2012;46:488-97
   Google Scholar
• Wingett D, Long A, Kelleher D, et al. Pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J Immunol 1996;156:49-57
   Google Scholar
• Rainio EM, Sandholm J, Koskinen PJ. Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase. J Immunol 2002;168:1524-7
   PubMed Web of Science ®Google Scholar
• Linowes BA, Ligons DL, Nam AS, et al. Pim1 permits generation and survival of CD4(+) T cells in the absence of γc cytokine receptor signaling. Eur J Immunol 2013;43:2283-94
   Google Scholar
• Amaravadi R, Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 2005;115:2618-24
   PubMed Web of Science ®Google Scholar
• Brault L, Gasser C, Bracher F, et al. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica 2010;95:1004-15
   PubMed Web of Science ®Google Scholar
• Swords R, Kelly K, Carew J, et al. The Pim kinases: new targets for drug development. Curr Drug Targets 2011;12:2059-66
   PubMed Web of Science ®Google Scholar
• Grundler R, Brault L, Gasser C, et al. Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration. J Exp Med 2009;206:1957-70
   PubMed Web of Science ®Google Scholar
• Alarcón-Riquelme ME. Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus. Arthritis Res Ther 2004;6:169-73
   PubMedGoogle Scholar
• Brenner O, Levanon D, Negreanu V, et al. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci USA 2004;101:16016-21
   PubMed Web of Science ®Google Scholar
• Fainaru O, Woolf E, Lotem J, et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004;23:969-79
   PubMed Web of Science ®Google Scholar
• Fainaru O, Shseyov D, Hantisteanu S, et al. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci USA 2005;102:10598-603
   PubMed Web of Science ®Google Scholar
• Okuda T, van Deursen J, Hiebert SW, et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996;84:321-30
   PubMed Web of Science ®Google Scholar
• Miyoshi H, Shimizu K, Kozu T, et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukaemia are clustered within a limited region of a single gene. AML1. Proc Natl Acad Sci USA 1991;88:10431-4
   PubMed Web of Science ®Google Scholar
• Osato M, Asou N, Abdalla E, et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 1999;93:1817-24
   PubMed Web of Science ®Google Scholar
• Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbf1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54
   PubMed Web of Science ®Google Scholar
• Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64
   PubMed Web of Science ®Google Scholar
• Mundlos S, Otto F, Mundlos C, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997;89:773-9
   PubMed Web of Science ®Google Scholar
• Levanon D, Negreanu V, Bernstein Y, et al. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994;23:425-32
   PubMed Web of Science ®Google Scholar
• Haagerup A, Bjerke T, Schiøtz PO, et al. Asthma and atopy - a total genome scan for susceptibility genes. Allergy 2002;57:680-6
   PubMedGoogle Scholar
• Calabi F, Rhodes M, Williamson P, et al. Identification and chromosomal mapping of a third mouse runt-like locus. Genomics 1995;26:607-10
   Google Scholar
• Christensen U, Møller-Larsen S, Nyegaard M, et al. Linkage of atopic dermatitis to chromosomes 4q22, 3p24 and 3q21. Hum Genet 2009;126:549-57
   Google Scholar
• Levanon D, Bettoun D, Harris-Cerruti C, et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J 2002;21:3454-63
   PubMed Web of Science ®Google Scholar
• Inoue K, Ozaki S, Shiga T, et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nature Neurosci 2002;5:946-54
   PubMed Web of Science ®Google Scholar
• Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-24
   PubMed Web of Science ®Google Scholar
• Nakase Y, Sakakura C, Miyagawa K, et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Br J Cancer 2005;92:562-9
   Google Scholar
• Hollingsworth JW, Maruoka S, Boon K, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008;118:3462-9
   PubMed Web of Science ®Google Scholar
• Weersma RK, Zhou L, Nolte IM, et al. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Inflamm Bowel Dis 2008;14:1615-22
   Google Scholar
• Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002;111:621-33
   PubMed Web of Science ®Google Scholar
• Naoe Y, Setoguchi R, Akiyama K, et al. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the IL4 silencer. J Exp Med 2007;204:1749-55
   Google Scholar
• Tahirov TH, Inoue-Bungo T, Morii H, et al. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell 2001;104:755-67
   PubMed Web of Science ®Google Scholar
• Huang G, Shigesada K, Ito K, et al. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J 2001;20:723-33
   PubMed Web of Science ®Google Scholar
• Cruz-Guilloty F, Pipkin ME, Djuretic IM, et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med 2009;206:51-9
   PubMed Web of Science ®Google Scholar
• Djuretic IM, Levanon D, Negreanu V, et al. Transcription factors T-bet and Runx3 cooperate to activate IFNγ and silence IL4 in T helper type 1 cells. Nat Immunol 2007;8:145-53
   PubMed Web of Science ®Google Scholar
• Kohu K, Ohmori H, Wong WF, et al. The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3. J Immunol 2009;183:7817-24
   PubMed Web of Science ®Google Scholar
• Yagi R, Junttila IS, Wei G, et al. The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity 2010;32:507-17
   PubMed Web of Science ®Google Scholar
• Aho TL, Sandholm J, Peltola KJ, et al. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity. BMC Cell Biol 2006;7:21-9
   Google Scholar
• Kim HY, Oh BC, Choi JK, et al. Pim1 kinase phosphorylates and stabilizes Runx3 and alters its subcellular localization. J Cell Biochem 2008;105:1048-58
   Google Scholar